This article is a detailed account of the Affordable Care Act. The following materials were submitted on August 28, 2013. New regulations, guidance, FAQs, and announcements may be issued after August 28, 2013, which may alter the content of some of this article.
This article focuses on key points in relation to the OFT process when applied to FTs and NHS trusts.
This comprehensive checklist identifies information for the due diligence process in connection with a proposed transaction between two parties. The entity responsible for producing requested documents should not have to create new documents. Production requests may seem duplicative; however, this is intentional in an effort to capture all relevant materials.
This newsletter is published by the law firm Venable LLP. It is not intended to provide legal advice or opinion. Such advice may only be given when related to specific fact situations that Venable has accepted an engagement as counsel to address.
This paper is intended to provide a broad overview of the Patient Protection and Affordable Care Act (“ACA”) as it applies to employers that sponsor health plans. This outline does not address all the applicable aspects and nuances of ACA as it applies to employer-sponsored health plans, as thousands of pages of applicable guidance have been issued on this topic over the past several years. Rather, its purpose is to introduce employers to some of the key provisions of health care reform that impact employer-sponsored health plans. As you review the materials herein, please remember that the application of the rules described is highly fact specific and this paper is not intended to provide legal advice or a legal opinion.
A detailed due diligence checklist form licensed from the American Health Lawyers Association, adapted, revised and fully annotated by Ropes & Gray, LLC with assistance from Bloomberg Law editorial staff. The checklist included is a sample for a simple, small-dollar transaction in the United States involving a general healthcare provider or supplier.
This check card is a printable resource with practical advice for the dos and don'ts of HIPAA privacy.
This article addresses how pharmaceutical companies take precautions against activist firms when using their shares as currency for an acquisition. These bans have gone largely unnoticed by the activist managers, who say shareholders may be harmed when a company limits who can buy its shares.
This is an Ohio State University Wexner Medical Center HIPAA breach analysis form.
This protocol was issued to establish a process for health care providers to voluntarily identify, disclose, and resolve instances of potential fraud involving the Federal health care programs (as defined in section 1128B(f) of the Social Security Act (the Act), 42 U.S.C. 1320a–7b(f)).